162 related articles for article (PubMed ID: 24625218)
1. HIV-related neurocognitive impairment screening: the patient's perspective on its utility and psychological impact.
Nightingale A; Ratcliffe D; Leonidou L; Margetts A; Asboe D; Gazzard B; Catalan J; Barber TJ
AIDS Care; 2014; 26(8):1036-41. PubMed ID: 24625218
[TBL] [Abstract][Full Text] [Related]
2. Simple screening for neurocognitive impairment in routine HIV outpatient care: is it deliverable?
Parry S; Zetler S; Kentridge A; Petrak J; Barber T
AIDS Care; 2017 Oct; 29(10):1275-1279. PubMed ID: 28292203
[TBL] [Abstract][Full Text] [Related]
3. Low levels of neurocognitive impairment detected in screening HIV-infected men who have sex with men: The MSM Neurocog Study.
Barber TJ; Bansi L; Pozniak A; Asboe D; Nelson M; Moyle G; Davies N; Margetts A; Ratcliffe D; Catalan J; Boffito M; Gazzard B
Int J STD AIDS; 2017 Jun; 28(7):715-722. PubMed ID: 27510645
[TBL] [Abstract][Full Text] [Related]
4. Screening for neurocognitive impairment in HIV-positive adults aged 50 years and older: Montreal Cognitive Assessment relates to self-reported and clinician-rated everyday functioning.
Fazeli PL; Casaletto KB; Paolillo E; Moore RC; Moore DJ; The Hnrp Group
J Clin Exp Neuropsychol; 2017 Nov; 39(9):842-853. PubMed ID: 28122474
[TBL] [Abstract][Full Text] [Related]
5. Screening for HIV-Associated Neurocognitive Impairment: Relevance of Psychological Factors and Era of Commencement of Antiretroviral Therapy.
Herrmann S; McKinnon E; Skinner M; Duracinsky M; Chaney R; Locke V; Mastaglia F
J Assoc Nurses AIDS Care; 2019; 30(1):42-50. PubMed ID: 30586348
[TBL] [Abstract][Full Text] [Related]
6. Validity of the International HIV Dementia Scale in South Africa.
Joska JA; Westgarth-Taylor J; Hoare J; Thomas KG; Paul R; Myer L; Stein DJ
AIDS Patient Care STDS; 2011 Feb; 25(2):95-101. PubMed ID: 21214343
[TBL] [Abstract][Full Text] [Related]
7. Validation of the International HIV Dementia Scale as a Screening Tool for HIV-Associated Neurocognitive Disorders in a German-Speaking HIV Outpatient Clinic.
Marin-Webb V; Jessen H; Kopp U; Jessen AB; Hahn K
PLoS One; 2016; 11(12):e0168225. PubMed ID: 27992497
[TBL] [Abstract][Full Text] [Related]
8. Screening for neurocognitive impairment, depression, and anxiety in HIV-infected patients in Western Europe and Canada.
Robertson K; Bayon C; Molina JM; McNamara P; Resch C; Muñoz-Moreno JA; Kulasegaram R; Schewe K; Burgos-Ramirez A; De Alvaro C; Cabrero E; Guion M; Norton M; van Wyk J
AIDS Care; 2014; 26(12):1555-61. PubMed ID: 25029599
[TBL] [Abstract][Full Text] [Related]
9. Determining optimal impairment rating methodology for a new HIV-associated neurocognitive disorder screening procedure.
Kamminga J; Bloch M; Vincent T; Carberry A; Brew BJ; Cysique LA
J Clin Exp Neuropsychol; 2017 Oct; 39(8):753-767. PubMed ID: 28052738
[TBL] [Abstract][Full Text] [Related]
10. Assessing the role of peripheral CD8 T cells in neurocognitive impairment in HIV-infected men who have sex with men: data from the MSM Neurocog Study.
Rawson TM; Dubb S; Pozniak A; Kelleher WP; Mandalia S; Gazzard B; Barber TJ
Int J STD AIDS; 2015 Feb; 26(2):128-32. PubMed ID: 24759562
[TBL] [Abstract][Full Text] [Related]
11. HIV and Cognitive Impairment in Clinical Practice: The Evaluation of a Stepwise Screening Protocol in Relation to Clinical Outcomes and Management.
Hakkers CS; Kraaijenhof JM; van Oers-Hazelzet EB; Visser-Meily AJMA; Hoepelman AIM; Arends JE; Barth RE
AIDS Patient Care STDS; 2017 Sep; 31(9):363-369. PubMed ID: 28783374
[TBL] [Abstract][Full Text] [Related]
12. A brief and feasible paper-based method to screen for neurocognitive impairment in HIV-infected patients: the NEU screen.
Muñoz-Moreno JA; Prats A; Pérez-Álvarez N; Fumaz CR; Garolera M; Doval E; Negredo E; Ferrer MJ; Clotet B;
J Acquir Immune Defic Syndr; 2013 Aug; 63(5):585-92. PubMed ID: 24135776
[TBL] [Abstract][Full Text] [Related]
13. Correlations between computerized battery testing and a memory questionnaire for identification of neurocognitive impairment in HIV type 1-infected subjects on stable antiretroviral therapy.
Garvey LJ; Yerrakalva D; Winston A
AIDS Res Hum Retroviruses; 2009 Aug; 25(8):765-9. PubMed ID: 19678764
[TBL] [Abstract][Full Text] [Related]
14. Are MMSE and HDS-R neuropsychological tests adequate for screening HIV-associated neurocognitive disorders?
Nakazato A; Tominaga D; Tasato D; Miyagi K; Nakamura H; Haranaga S; Higa F; Tateyama M; Fujita J
J Infect Chemother; 2014 Mar; 20(3):217-9. PubMed ID: 24462448
[TBL] [Abstract][Full Text] [Related]
15. Cognitive screening in treatment-naïve HIV-infected individuals in Hong Kong - a single center study.
Chan FCC; Chan P; Chan I; Chan A; Tang THC; Lam W; Fong WC; Lee MP; Li P; Chan GHF
BMC Infect Dis; 2019 Feb; 19(1):156. PubMed ID: 30760220
[TBL] [Abstract][Full Text] [Related]
16. Is the use of the QPC cognitive complaints questionnaire relevant for the screening strategy of HIV-Associated neurocognitive disorders?
Zaegel-Faucher O; Laroche H; Tixier M; Morisseau V; Obry-Roguet V; Poizot-Martin I
AIDS Care; 2021 Mar; 33(3):389-397. PubMed ID: 32279542
[TBL] [Abstract][Full Text] [Related]
17. Neurocognitive screening tools in HIV/AIDS: comparative performance among patients exposed to antiretroviral therapy.
Skinner S; Adewale AJ; DeBlock L; Gill MJ; Power C
HIV Med; 2009 Apr; 10(4):246-52. PubMed ID: 19187172
[TBL] [Abstract][Full Text] [Related]
18. HIV-related neurocognitive impairment--a review.
Rackstraw S
Psychol Health Med; 2011 Oct; 16(5):548-63. PubMed ID: 21745034
[TBL] [Abstract][Full Text] [Related]
19. A Comparison of Five Brief Screening Tools for HIV-Associated Neurocognitive Disorders in the USA and South Africa.
Joska JA; Witten J; Thomas KG; Robertson C; Casson-Crook M; Roosa H; Creighton J; Lyons J; McArthur J; Sacktor NC
AIDS Behav; 2016 Aug; 20(8):1621-31. PubMed ID: 26860536
[TBL] [Abstract][Full Text] [Related]
20. Screening for HIV-associated neurocognitive disorders in perinatally infected adolescents: youth-International HIV Dementia Scale validation.
Phillips NJ; Thomas KGF; Myer L; Sacktor N; Zar HJ; Stein DJ; Hoare J
AIDS; 2019 Apr; 33(5):815-824. PubMed ID: 30649059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]